300314 戴维医疗
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.7997.2514.91213.2839.500
总资产报酬率 ROA (%)0.6726.0004.11311.2398.084
投入资产回报率 ROIC (%)0.7787.0184.75712.8359.172

边际利润分析
销售毛利率 (%)49.91753.62156.47057.55358.552
营业利润率 (%)10.26916.89113.05327.71622.135
息税前利润/营业总收入 (%)14.02615.9129.99923.65917.805
净利润/营业总收入 (%)8.76414.90610.86523.87419.239

收益指标分析
经营活动净收益/利润总额(%)59.94678.716115.97688.26897.456
价值变动净收益/利润总额(%)23.45715.515-15.2066.974-4.361
营业外收支净额/利润总额(%)-2.2700.010-8.539-3.092-0.084

偿债能力分析
流动比率 (X)4.4843.7123.8805.0265.225
速动比率 (X)3.4282.9123.0964.2194.385
资产负债率 (%)14.34517.34817.14515.32715.457
带息债务/全部投入资本 (%)1.7972.2262.8851.5372.633
股东权益/带息债务 (%)5,434.3694,367.1253,339.6806,336.4513,639.962
股东权益/负债合计 (%)597.118476.437483.244552.428546.943
利息保障倍数 (X)3.519-16.234-4.932-7.335-4.130

营运能力分析
应收账款周转天数 (天)33.66021.69817.16211.89611.679
存货周转天数 (天)329.623254.815267.951210.992245.152